TG Therapeutics, Inc. (TGTX) – Buy Target: $24.50 or better

Buy Target: $24.50 or better
Sell Target: TradersPro Sell Signal

TG Therapeutics, Inc., a biopharmaceutical company, engages in developing and delivering medicines for patients with chronic lymphocytic leukemia (CLL), non-Hodgkin’s Lymphoma (NHL), and multiple sclerosis (MS). The company develops a robust B-cell directed research and development platform for identification of key B-cell pathways of interest and rapid clinical testing.

X